Nivolumab-ipilimumab combination granted priority review by FDA By Sharon Kell|2017-12-18T12:47:53+00:0018 Dec 2017|Drug treatments| The Food and Drug Adminitration in the US has granted [...] Read More Comments Off on Nivolumab-ipilimumab combination granted priority review by FDA
Immunotherapy combinations for kidney cancer By Sharon Kell|2016-12-07T15:29:04+00:007 Dec 2016|Drug treatments| In the following article, Dr Robert J. Motzer, a medical [...] Read More Comments Off on Immunotherapy combinations for kidney cancer